Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.33 CAD
Change Today 0.00 / 0.00%
Volume 33.0K
TLT On Other Exchanges
As of 9:35 AM 11/26/15 All times are local (Market data is delayed by at least 15 minutes).

theralase technologies inc (TLT) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/23/14 - C$0.78
52 Week Low
08/24/15 - C$0.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

theralase technologies inc (TLT) Related Businessweek News

No Related Businessweek News Found

theralase technologies inc (TLT) Details

Theralase Technologies Inc. designs, develops, manufactures, and markets laser technology used in biostimulative and biodestructive clinical applications. The company operates in two divisions, Therapeutic Laser Technology and Photo Dynamic Therapy. It engages in the production, marketing, and distribution of TLC-1000 and TLC-2000 laser technology for the treatment of pain, neural muscular skeletal conditions, and wound healing. The company is also involved in the research, development, and commercialization of the patented and patent pending TLC-3000 Photo Dynamic Compound technology through pre-clinical scientific research, technology development, and clinical trials to destroy cancers for oncological applications, as well as bacteria for human, animal, and sterilization applications. In addition, it operates a full service medical rehabilitation clinic in Toronto, Ontario for training and education of health-care practitioners. The company sells its products to licensed healthcare practitioners in Canada, the United States, and internationally. Theralase Technologies Inc. has strategic partnerships with University Health Network, Ontario Centers of Excellence for Photonics, National Research Council of Canada, Virginia Tech, The Scripps Research Institute, Mayo Clinic, University of Buffalo, and JSS Medical Research. The company is headquartered in Toronto, Canada.

theralase technologies inc (TLT) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: C$170.8K
Chief Financial Officer
Total Annual Compensation: C$129.6K
Compensation as of Fiscal Year 2014.

theralase technologies inc (TLT) Key Developments

Theralase Technologies Inc. Announces New Appointments

Theralase Technologies Inc. announced that it has appointed Dr. Elizabeth Angelevski as the Director of Clinical Education /Training and Dr. Alex Peplow as the Clinic Director of Theralase. Dr. Angelevski graduated from Canadian Memorial Chiropractic College ("CMCC") in 2009 and from McMaster University with a Bachelor of Science in Kinesiology (Honours) in 2005. She is a licensed chiropractor with an avid interest in sports injuries and rehabilitation. Dr. Angelevski will be responsible for: Providing clinical overview to the marketing program for the next generation therapeutic laser; Training all healthcare practitioners on the safe and effective use of the next generation therapeutic laser; General management of the Theralase clinic. Dr. Peplow will be responsible for: Managing the day to day operations of the Theralase clinic; Treating patients in the Theralase clinic. Both Dr. Angelevski and Dr. Peplow will utilize the next generation therapeutic laser in the clinic working in conjunction with Theralase's Key Opinion Leaders ("KOLs") to optimize the technology, provide continuing feedback and support to the ever growing customer base in Canada, the US and internationally.

Theralase Technologies Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 10:00 AM

Theralase Technologies Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 10:00 AM. Venue: The Encore at Wynn, 3131 S Las Vegas Blvd, Las Vegas, NV 89109, United States.

Theralase Technologies Inc. Submits Anti-Cancer Technology to the Research Ethics Board of Princess Margaret Cancer Center, University Health Network for Approval

Theralase Technologies Inc. announced that it has submitted its anti-cancer technology to the Research Ethics Board (REB) of Princess Margaret Cancer Center, University Health Network (UHN) for approval. The REB is responsible for reviewing the anti-cancer technology and assessing it from a clinical viewpoint. The anti-cancer technology consists of the company’s lead Photo Dynamic Compound (PDC), TLD-1433, which is light activated by the proprietary Theralase TLC-3200 Oncology Laser System for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). The REB, pending review, will authorize the UHN clinical team to commence enrolling patients, inflicted with NMIBC, into a Phase Ib clinical trial to study the effects of the technology as determined by the primary outcome measures of safety and tolerability, and as an exploratory endpoint, efficacy. Pending approval of the following applications, UHN will commence enrolling patients: (1) Health Canada Clinical Trial Application (CTA) (Submission Complete); (2) Health Canada Investigational Testing Authorization (ITA) (Submission Complete); (3) UHN REB (Submission Complete).


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TLT:CN C$0.33 CAD 0.00

TLT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TLT.
View Industry Companies

Industry Analysis


Industry Average

Valuation TLT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 20.5x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 18.5x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact THERALASE TECHNOLOGIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at